Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,127.20
(
0.47%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
98.79
(
-1.85%
)
Bitcoin
74,054.91
(
0.15%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: acgood post# 106537

Monday, 10/18/2010 7:13:35 PM

Monday, October 18, 2010 7:13:35 PM

Post# of 257253

Who is the company that filed the Lovenox application for only one little-used dosing form?

HSP—see #msg-33960572.

Maybe that is the partner and Teva was not interested in that formulation?

Teva’s Lovenox partner is not HSP. Moreover, the word partner probably gives Teva more credit than it deserves; as far as I know, Teva did none of the Lovenox development work and is merely the regulatory and (prospective) distribution arm for the other company’s product.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now